See also this year's filing and all EDGAR filings for this company.
PDF Report 0001586105_2019_Zyla_Life_Sciences.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001586105, Zyla Life Sciences
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 54,517,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,281,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,059,000 |
| 3 | remainder_Assets | 2,076,000 |
| 4 | LiabilitiesCurrent | 33,145,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,776,883 |
| 9 | ResearchAndDevelopmentExpense | 39,499 |
| 10 | remainder_Expenses | 99,981,223 |
| 11 | remainder_Revenues | 29,726,314 |
| 12 | remainder_NetIncome | -171,163 |
| 13 | remainder_ComprehensiveNetIncome | 576,035 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 61,933,000 |
| 1 | Liabilities | 33,145,000 |
| 2 | Expenses | 115,797,605 |
| 3 | Revenues | 29,726,314 |
| 4 | StockholdersEquity | 28,788,000 |
| 5 | NetIncome | -86,242,454 |
| 6 | ComprehensiveNetIncome | -85,954,436 |
| 7 | BaseVar | 120,674,558 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.488 |
| 9 | EconomicCapitalRatio | 1.38 |
Edgar->Model Mapping
Feature Distribution
Change over Time
